
### [MONDO:0020247](http://purl.obolibrary.org/obo/MONDO_0020247)
**Label:** congenital vitreoretinal dysplasia

**Subclasses:** [MONDO:0012815](http://purl.obolibrary.org/obo/MONDO_0012815) (Coats plus syndrome), [MONDO:0019523](http://purl.obolibrary.org/obo/MONDO_0019523) (Walker-Warburg syndrome), [MONDO:0014683](http://purl.obolibrary.org/obo/MONDO_0014683) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9), [MONDO:0019631](http://purl.obolibrary.org/obo/MONDO_0019631) (persistent hyperplastic primary vitreous), 

**Corr. equiv. classes:** [OMIM:253800](http://purl.obolibrary.org/obo/OMIM_253800), [OMIM:615041](http://purl.obolibrary.org/obo/OMIM_615041), [OMIM:615181](http://purl.obolibrary.org/obo/OMIM_615181), [OMIM:615287](http://purl.obolibrary.org/obo/OMIM_615287), [OMIM:613150](http://purl.obolibrary.org/obo/OMIM_613150), [OMIM:613153](http://purl.obolibrary.org/obo/OMIM_613153), [OMIM:617341](http://purl.obolibrary.org/obo/OMIM_617341), [OMIM:613154](http://purl.obolibrary.org/obo/OMIM_613154), [Orphanet:313838](http://www.orpha.net/ORDO/Orphanet_313838), [OMIM:612199](http://purl.obolibrary.org/obo/OMIM_612199), [OMIM:253280](http://purl.obolibrary.org/obo/OMIM_253280), [OMIM:616538](http://purl.obolibrary.org/obo/OMIM_616538), [OMIM:614830](http://purl.obolibrary.org/obo/OMIM_614830), [OMIM:614643](http://purl.obolibrary.org/obo/OMIM_614643), [OMIM:615249](http://purl.obolibrary.org/obo/OMIM_615249), [Orphanet:899](http://www.orpha.net/ORDO/Orphanet_899), [OMIM:221900](http://purl.obolibrary.org/obo/OMIM_221900), [OMIM:611308](http://purl.obolibrary.org/obo/OMIM_611308), [Orphanet:91495](http://www.orpha.net/ORDO/Orphanet_91495), [Orphanet:370997](http://www.orpha.net/ORDO/Orphanet_370997), 

**Class expressions from DL-Learner:**

- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) 61.29%
- [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0030724](http://purl.obolibrary.org/obo/HP_0030724) (Central nervous system cyst) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0011283](http://purl.obolibrary.org/obo/HP_0011283) (Abnormality of the metencephalon) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 61.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0011282](http://purl.obolibrary.org/obo/HP_0011282) (Abnormality of hindbrain morphology) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 61.29%


